10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2021 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | |
| Revenues | |||
| Premiums | $ 117,373 | 104,109 | 94,173 |
| Product revenue | 12,657 | 10,384 | 2,760 |
| Administrative fees and other revenue | 6,913 | 6,315 | 6,208 |
| Total operating revenue | 136,943 | 120,808 | 103,141 |
| Net investment income | 1,378 | 877 | 1,005 |
| Net gains on financial instruments | 318 | 182 | 67 |
| Total revenues | 138,639 | 121,867 | 104,213 |
| Expenses | |||
| Benefit expense | 102,645 | 88,045 | 81,786 |
| Cost of products sold | 10,895 | 8,953 | 1,992 |
| Selling, general and administrative expense | 15,914 | 17,450 | 13,364 |
| Interest expense | 798 | 784 | 746 |
| Amortization of other intangible assets | 441 | 361 | 338 |
| Loss on extinguishment of debt | 21 | 36 | 2 |
| Total expenses | 130,714 | 115,629 | 98,228 |
| Income before income tax expense | 7,925 | 6,238 | 5,985 |
| Income tax expense | 1,830 | 1,666 | 1,178 |
| Net income | 6,095 | 4,572 | 4,807 |
| Net loss attributable to noncontrolling interests | 9 | 0 | 0 |
| Shareholders net income | 6,104 | 4,572 | 4,807 |
| Shareholders net income per share | |||
| Basic net income per share | 25.04 | 18.23 | 18.81 |
| Diluted net income per share | 24.73 | 17.98 | 18.47 |
| Dividends per share | 4.52 | 3.80 | 3.20 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2021 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |